(1)
Langabeer, S.; Haslam, K.; Crampe, M.; MacDonagh, B.; McHugh, J. Suboptimal Molecular Response to Tyrosine Kinase Inhibition Associated With Acquisition of a T240A ABL1 Kinase Domain Mutation in a Patient With Chronic Myeloid Leukemia. Exp. oncol. 2023, 41, 82-83.